Investegate |LIDDS AB Announcements | LIDDS AB: NanoZolid®-formulated Docetaxel is Safe and Tolerable Showing Signs of Clinical Efficacy
Investegate announcements from LIDDS AB, NanoZolid®-formulated Docetaxel is Safe and Tolerable Showing Signs of Clinical Efficacy